Skip to main content
All CollectionsAssessment Descriptions + Scoring Interpretations
DSM-5 Severity Measure for Agoraphobia-Adult (DSM-5 Agoraphobia)
DSM-5 Severity Measure for Agoraphobia-Adult (DSM-5 Agoraphobia)
Updated over 4 months ago

Brief Description

The DSM-5 Severity Measure for Agoraphobia—Adult is a tool used to assess and monitor the severity of agoraphobia symptoms in adults. This measure was developed by the American Psychiatric Association and is designed to capture the frequency and intensity of agoraphobic symptoms over the past seven days. The questions focus on symptoms such as fear of leaving home, fear of being in open or crowded places, and physical symptoms like heart palpitations and dizziness. The total score helps clinicians determine the severity of agoraphobia and monitor changes over time, aiding in treatment planning and evaluation of therapeutic outcomes.


Assessment Administration Type

Self-report


Number of questions

10


Age Range for Administration

18+


Recommended Frequency of Administration

No recommended standard frequency. Blueprint recommends weekly or as clinically indicated.


Summary of Scoring and Interpretations

The DSM-5 Severity Measure for Agoraphobia-Adult consists of 10 questions, each rated on a 5-point Likert scale with values from 0 ("Never") to 4 ("All of the time"). The total score is calculated by summing all item responses and can range from 0 to 40, with higher scores indicating greater severity of agoraphobia. Blueprint displays the total average score (i.e., sum of all item responses divided by 10), with higher scores also indicating greater severity; see interpretations of total average scores in the table below:

Total Average Score

Interpretation

0

None

1

Mild

2

Moderate

3

Severe

4

Extreme


Blueprint Adjustments

N/A


Clinical Considerations

  • Estimated time for completion: 1-2 minutes.

  • The DSM-5 Agoraphobia was designed for use in assessing agoraphobia symptoms after an individual has received a diagnosis of agoraphobia (or clinically significant agoraphobia symptoms). It is not meant to be used as a diagnostic tool.


Citation

American Psychiatric Association. (2013). Diagnostic and statistical manual of mental disorders (5th Ed.). Arlington, VA: American Psychiatric Publishing.


Relevant Articles + Further Resources


We're here for you!

Do you have follow-up questions? We're here and happy to help!

Send us an email at help@blueprint-health.com or use the help messenger in the lower right corner to speak with our Support team. 💪🏼

Did this answer your question?